Skip to content

MARSHALL WACE, LLP: ACCV position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of MARSHALL WACE, LLP on ACCV, newest first. How the timeline and the estimate are built.

MARSHALL WACE, LLP held 1,200,000 ACCV shares at 2026-09-30 per its 13F-HR filed 2026-11-13.

the latest 13F is the newest step

  1. period ended2026-09-30
    13F 1,200,000 shares
    Change vs previous 13F not available

    0.02% of the 13F portfolio, value $21,540,003.

    13F-HR 0001318757-26-000012 filed by MARSHALL WACE, LLP
    Accepted , ingested